1 |
Amniotic epithelial cells |
Amniotic Epithelial Cells |
- |
- |
- |
026 [1] 26 💬 |
2 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
3 |
Ciclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 [13] 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
4 |
Costicosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |
5 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
6 |
Doxorubicin |
Doxorubicin |
[1] D03899 D03899 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
026 [4] 26, 28, 34, 331 💬 |
7 |
Doxorubicin hydrochloride |
Doxorubicin |
[1] D03899 D03899 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
026 [3] 26, 34, 331 💬 |
8 |
Etoposide |
Etoposide |
[2] D00125 D00125, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
011 [11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
9 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
10 |
Hu mik-beta-1 |
- |
- |
- |
- |
026 [1] 26 💬 |
11 |
Human interferon beta |
Human interferon beta |
- |
- |
- |
013 [2] 13, 26 💬 |
12 |
Interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 [5] 25, 26, 28, 56, 96 💬 |
13 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 [5] 13, 20, 26, 96, 97 💬 |
14 |
Interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [4] 13, 26, 96, 97 💬 |
15 |
Kw-0761 |
- |
- |
- |
- |
026 [1] 26 💬 |
16 |
Kw-0761 0.3 mg/kg iv |
- |
- |
- |
- |
026 [1] 26 💬 |
17 |
Lamivudine |
Lamivudine |
[1] D00353 D00353 💬 |
- |
- |
026 [6] 26, 42, 46, 135, 265, 325 💬 |
18 |
Lenalidomide |
Lenalidomide |
[1] D04687 D04687 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [7] 16, 26, 28, 34, 49, 284, 300 💬 |
19 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
20 |
Mogamulizumab |
Mogamulizumab |
[1] D09761 D09761 💬 |
CCR4 [1] CCR4 💬 |
Chemokine signaling pathway [5] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
026 [1] 26 💬 |
21 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
22 |
Nk cells |
Natural Killer Cell |
- |
- |
- |
026 [1] 26 💬 |
23 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
24 |
Other: pharmacogenomic study |
- |
- |
- |
- |
026 [1] 26 💬 |
25 |
Pentosan polysulfate |
Pentosan polysulfate |
[1] D05428 D05428 💬 |
- |
- |
019 [3] 19, 26, 226 💬 |
26 |
Pentoxifylline |
Pentoxifylline |
[1] D00501 D00501 💬 |
- |
- |
026 [10] 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
27 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
28 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
29 |
Propantheline |
Propantheline |
[1] D00481 D00481 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 [1] 26 💬 |
30 |
Propantheline bromide |
Propantheline |
[1] D00481 D00481 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
026 [1] 26 💬 |
31 |
Raltegravir |
Raltegravir |
[1] D06676 D06676 💬 |
- |
- |
013 [4] 13, 26, 93, 265 💬 |
32 |
Raltegravir and zidovudine |
Raltegravir |
[2] D00413 D00413, D06676 D06676 💬 |
- |
- |
026 [1] 26 💬 |
33 |
Recombinant human interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 [1] 26 💬 |
34 |
Recombinant interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 [2] 26, 28 💬 |
35 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
36 |
Tamibarotene |
Tamibarotene |
[1] D01418 D01418 💬 |
RARA [1] RARA 💬 |
Acute myeloid leukemia [5] Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
026 [2] 26, 96 💬 |
37 |
Valproic acid |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [10] 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
38 |
Valproid acid plus corticosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |
39 |
Vincristine |
Vincristine |
[2] D02197 D02197, D08679 D08679 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
026 [3] 26, 34, 331 💬 |
40 |
Vincristine sulfate |
Sulfate ion |
[2] D02197 D02197, D08679 D08679 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
026 [2] 26, 34 💬 |
41 |
Zidovudine |
Zidovudine |
[1] D00413 D00413 💬 |
- |
- |
025 [6] 25, 26, 135, 265, 325, 331 💬 |
42 |
Zidovudine/lamivudine |
Lamivudine |
[2] D00353 D00353, D00413 D00413 💬 |
- |
- |
026 [1] 26 💬 |